Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.


Payers Manipulate Definition of Necessity

September 29th 2016

When it comes to health coverage, most Americans face an unnerving reality—they have no idea what is covered under their health insurance policy until they are affected by illness or disease.

Throw a House Instead of a Marble

September 24th 2016

As the cost comes down due to new technologies and as studies mature, maybe the value equation for common malignancies will favor proton beam therapy. However, it is hard to imagine how throwing a house will ever be as cost-efficient as throwing a marble.

Don't Get Caught Behind the MACRA Curve

September 22nd 2016

Although the MIPS and MACRA rule is preliminary and subject to change, CMS is clearly putting a lot of weight into it, and the act will be a major part of oncology practice.

CMS Value Model Doesn't Do It All

September 21st 2016

Andrew L. Pecora, MD, discusses the value changes that CMS is mandating, and how it takes enormous planning and study.

CMS Backs Up CVS Network Exclusions Under Part D

September 20th 2016

In its re-interpretation of CMS policy for Medicare Part D drug dispensing, CVS Health has gone against years of allowing in-house physician dispensaries to participate in Medicare Part D.

Proton Beam Therapy Almost Within Reach for Independent Oncology Practices

September 19th 2016

The first proton beam therapy units cost huge amounts of money and were well beyond the means of all but the most well-financed cancer centers. However, this technology is vastly cheaper than before.

Expert Discusses Impact of Atezolizumab in Advanced Bladder Cancer

September 15th 2016

The PD-L1 inhibitor atezolizumab has been found to be non-toxic and has demonstrated a major survival advantage in patients with metastatic urothelial bladder cancer.

CMS Hits the Brakes on MACRA Reforms

September 9th 2016

CMS has scaled back the implementation of physician reporting requirements under the Quality Payment Program of medical value improvement created under the Medicare Access and CHIP Reauthorization Act legislation.

Automating the Search for Financial Assistance

September 8th 2016

Higher insurance premiums, deductibles, and co-pays, along with the increased cost of cancer care, have made it more complicated to find aid.

FDA Grants Pembrolizumab Priority Review in Frontline NSCLC

September 7th 2016

The FDA has granted a priority review to a supplemental biologics license application for pembrolizumab (Keytruda) as a first-line treatment for patients with PD-L1–positive non–small cell lung cancer.

The Oncology Care Model: Roadmap or Distraction for Commercial Payers?

September 6th 2016

It's clear that Medicare needs a proactive cancer strategy, hence the launch of the Oncology Care Model.

CVS Cuts In-House Dispensaries Out of Part D Plan

September 2nd 2016

A move by CVS Health to place in-house physician dispensaries out-of-network for purposes of Medicare Part D drug payment would force hundreds of thousands of cancer patients across the country to find alternate sources for their oral oncolytic drugs.

Staffing Costs for Oncology Practices Soar Amid Deluge of Paperwork

August 24th 2016

Preauthorizations for chemotherapy drugs and payers’ differing administrative requirements are two of the main contributors to greater hiring needs. Oncologists and practice managers also cite frequent coverage denials, lengthy appeal processes, payerspecific clinical pathways, financial counseling for underinsured patients, data-tracking initiatives, and night and weekend nurse triage services.

Protect Against Rising Medical Data Fraud

August 23rd 2016

Oncology practices should protect themselves from the danger of having their IT systems hacked by having a risk analysis done to identify potential access and compromise points.

Pfizer Oncology Reach Expanding With Medivation Acquisition

August 22nd 2016

Pfizer has announced plans to acquire the biopharmaceutical company Medivation, which is the developer of the androgen receptor inhibitor enzalutamide (Xtandi).

Electronic Health Records: Our Story

August 20th 2016

Despite the anxiety and a few tears, Pontchartrain Cancer Center made the conscious decision to "buy in" to the concept and worked as a group to prepare for and implement electronic health records.

Dr. Pecora on Oncology Care Model Innovations

August 19th 2016

Andrew L. Pecora, MD, president of the Physician Services Division and chief innovation officer at Hackensack Meridian Health, discusses the Oncology Care Model (OCM) and other aspects of healthcare reform.

Patient Safety Now Includes Data Security

August 14th 2016

We consider what we do to patients through prescription or procedure as a potential source of harm, followed less so by our behavior, when we fail to be caring or courteous.

Build Referrals and Strengthen Revenues

August 12th 2016

Multiple resources are available to help community oncologists maintain success by increasing awareness of their practice, providing the most innovative treatments to their patients, and preparing for the future of oncology care.

Dr. Pecora on How the OCM Will Transform Operations For His Physician Group

August 12th 2016

Andrew L. Pecora, MD, president of the Physician Services Division and chief innovation officer at Hackensack Meridian Health, discusses the Oncology Care Model (OCM) and other aspects of healthcare reform.

NEXT PAGE
PREVIOUS PAGE